Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick S Buckner

Showing results (41-50 of 113) with videos related to

Pageof 12
Sort By:
ACS Medicinal Chemistry Letters|July 26, 2017
New Class of Antitrypanosomal Agents Based on ImidazopyridinesDaniel G Silva, J Robert Gillespie, Ranae M Ranade, et al.
Bioorganic & Medicinal Chemistry|February 12, 2017
Discovery of N-(2-aminoethyl)-N-benzyloxyphenyl benzamides: New potent Trypanosoma brucei inhibitorsAndriy Buchynskyy, J Robert Gillespie, Matthew A Hulverson, et al.
Molecular and Biochemical Parasitology|March 5, 2003
Protein farnesyl and N-myristoyl transferases: piggy-back medicinal chemistry targets for the development of antitrypanosomatid and antimalarial therapeuticsMichael H Gelb, Wesley C Van Voorhis, Frederick S Buckner, et al.
ACS Medicinal Chemistry Letters|January 19, 2019
Triazolopyrimidines and Imidazopyridines: Structure-Activity Relationships and in Vivo Efficacy for TrypanosomiasisPendem Nagendar, J Robert Gillespie, Zackary M Herbst, et al.
Journal of Medicinal Chemistry|May 1, 2010
Second generation analogues of the cancer drug clinical candidate tipifarnib for anti-Chagas disease drug discoveryJames M Kraus, Hari Babu Tatipaka, Sarah A McGuffin, et al.
Molecular and Biochemical Parasitology|May 14, 2013
Crystal structures of Plasmodium falciparum cytosolic tryptophanyl-tRNA synthetase and its potential as a target for structure-guided drug designCho Yeow Koh, Jessica E Kim, Alberto J Napoli, et al.
Acta Crystallographica. Section F, Structural Biology Communications|April 11, 2018
The crystal structure of the drug target Mycobacterium tuberculosis methionyl-tRNA synthetase in complex with a catalytic intermediateXimena Barros-Álvarez, Stewart Turley, Ranae M Ranade, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|March 3, 2007
The structure of Plasmodium vivax phosphatidylethanolamine-binding protein suggests a functional motif containing a left-handed helixTracy Arakaki, Helen Neely, Erica Boni, et al.
Journal of Medicinal Chemistry|December 20, 2016
Urea Derivatives of 2-Aryl-benzothiazol-5-amines: A New Class of Potential Drugs for Human African TrypanosomiasisDonald A Patrick, J Robert Gillespie, Joshua McQueen, et al.
Chemmedchem|October 20, 2020
Synthesis and Structure-Activity Relationships of Imidazopyridine/Pyrimidine- and Furopyridine-Based Anti-infective Agents against TrypanosomiasesDaniel G Silva, Anna Junker, Shaiani M G de Melo, et al.
Pageof 12

Showing results (41-50 of 113) with videos related to

Sort By:
Pageof 12
ACS Medicinal Chemistry Letters|July 26, 2017
New Class of Antitrypanosomal Agents Based on ImidazopyridinesDaniel G Silva, J Robert Gillespie, Ranae M Ranade, et al.
Bioorganic & Medicinal Chemistry|February 12, 2017
Discovery of N-(2-aminoethyl)-N-benzyloxyphenyl benzamides: New potent Trypanosoma brucei inhibitorsAndriy Buchynskyy, J Robert Gillespie, Matthew A Hulverson, et al.
Molecular and Biochemical Parasitology|March 5, 2003
Protein farnesyl and N-myristoyl transferases: piggy-back medicinal chemistry targets for the development of antitrypanosomatid and antimalarial therapeuticsMichael H Gelb, Wesley C Van Voorhis, Frederick S Buckner, et al.
ACS Medicinal Chemistry Letters|January 19, 2019
Triazolopyrimidines and Imidazopyridines: Structure-Activity Relationships and in Vivo Efficacy for TrypanosomiasisPendem Nagendar, J Robert Gillespie, Zackary M Herbst, et al.
Journal of Medicinal Chemistry|May 1, 2010
Second generation analogues of the cancer drug clinical candidate tipifarnib for anti-Chagas disease drug discoveryJames M Kraus, Hari Babu Tatipaka, Sarah A McGuffin, et al.
Molecular and Biochemical Parasitology|May 14, 2013
Crystal structures of Plasmodium falciparum cytosolic tryptophanyl-tRNA synthetase and its potential as a target for structure-guided drug designCho Yeow Koh, Jessica E Kim, Alberto J Napoli, et al.
Acta Crystallographica. Section F, Structural Biology Communications|April 11, 2018
The crystal structure of the drug target Mycobacterium tuberculosis methionyl-tRNA synthetase in complex with a catalytic intermediateXimena Barros-Álvarez, Stewart Turley, Ranae M Ranade, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|March 3, 2007
The structure of Plasmodium vivax phosphatidylethanolamine-binding protein suggests a functional motif containing a left-handed helixTracy Arakaki, Helen Neely, Erica Boni, et al.
Journal of Medicinal Chemistry|December 20, 2016
Urea Derivatives of 2-Aryl-benzothiazol-5-amines: A New Class of Potential Drugs for Human African TrypanosomiasisDonald A Patrick, J Robert Gillespie, Joshua McQueen, et al.
Chemmedchem|October 20, 2020
Synthesis and Structure-Activity Relationships of Imidazopyridine/Pyrimidine- and Furopyridine-Based Anti-infective Agents against TrypanosomiasesDaniel G Silva, Anna Junker, Shaiani M G de Melo, et al.
Pageof 12